ShengFengCaiMDPhD

PubMed

• 41 citations
  Targeting Lysine-Specific Demethylase 1 Rescues Major Histocompatibility Complex Class I Antigen Presentation and Overcomes Programmed Death-Ligand 1 Blockade Resistan...
  Evelyn M Nguyen, Hirokazu Taniguchi, Joseph M Chan, Yingqian A Zhan, Xiaoping Chen
  Journal of Thoracic Oncology. 2022-08-01
• 643 citations
  Granzyme B and Perforin Are Important for Regulatory T Cell-Mediated Suppression of Tumor Clearance
  Xuefang Cao, Sheng F. Cai, Todd A. Fehniger, Jiling Song, Lynne Collins
  Immunity. 2007-10-26
• 109 citations
  Clinical and molecular predictors of response and survival following venetoclax therapy in relapsed/refractory AML
  Maximilian Stahl, Kamal Menghrajani, Andriy Derkach, Alexander Chan, Wenbin Xiao
  Blood Advances. 2021-03-09

Journal Articles

• Article HOXA9 Reprograms the Enhancer Landscape to Promote Leukemogenesis  
  Ross L Levine, Jay L Hess, Sheng Cai, Scott A Armstrong, ScienceDirect

Abstracts/Posters

• A Phase Ib/II Study of the Histone Methyltransferase Inhibitor Pinometostat in Combination with Azacitidine in Patients with 11q23-Rearranged Acute Myeloid Leukemia
  Sheng F Cai, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Leukemia Cell of Origin Influences p53 Activity and Therapeutic Sensitivity Via an Evi1-Dependent Mechanism
  Sheng F. Cai, MD, PhD, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

• Loss of Plasmacytoid Dendritic Cell Differentiation Is Highly Predictive for Persistent Measurable Residual Disease and Poor Outcomes in Acute Myeloid Leukemia 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018